Abstract
The use and abuse of antimicrobials have led to the emergence of multi-drug resistant (MDR) bacteria and the spread of resistant organisms and is one of the major global threats for healthcare professionals. Alternatives to conventional antibiotics for combating resistant infections are the need of the hour. Nanotechnology-based drugs offer a ray of hope in the fight against MDR bacteria for patients as well as clinicians. Diverse types of nanomaterials have been synthesized from metallic particles with promising antibacterial activity. Efficacy of these nanomaterials depends on their interactions with bacterial cells and their mechanisms of action differ based on their physico-chemical properties. Development of novel and potent nanoantimicrobials requires in-depth knowledge of the physico-chemical properties of nanoparticles and the biological characteristics of bacteria. However, there is still a long way to go as there are major issues related to the toxicity and stability of nanoparticles. Moreover, the economic feasibility of transferring the technology from bench to bedside needs to be addressed. The present review highlights the antibacterial effects of nanoparticles, their mechanisms of action, factors affecting the activity of NPs and challenges of ongoing and future research.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
The discovery of antibiotics is considered to be one of the most significant advances in the field of medicine (Hwang et al. 2015). However, increasing drug resistance among infection-causing bacteria is slowly but surely leading to the emergence of a post-antibiotic era (Fernandes 2015). The emergence of multi-drug resistant (MDR) microbes has jeopardized the use of current antibiotic therapies (Courvalin 2016). To counter these MDR bacteria, higher doses of antibiotics are prescribed, sometimes causing toxic effects (Poulikakos et al. 2014). The treatment of drug-resistant infections has become difficult, expensive and complicated (Perez et al. 2007; Andrade et al. 2013a, b).
Drug resistance occurs naturally by selective pressure and by the horizontal transfer of resistance genes. This horizontal transfer by conjugation, transformation or transduction further worsens the situation as resistant genes disseminate to species that may be unrelated to the infection and which subsequently persist in natural environments (Doi et al. 2012; Piddock 2016). Another factor playing an important role in the inability of antibiotics to kill bacteria is the formation of biofilms by bacteria. Bacteria residing in biofilms are adhered to a surface and enclosed in a matrix of extra polymeric substances (EPS). EPS acts as a barrier against the entry of the antibiotics, making the bacteria less susceptible to antibacterial drugs. Thus, biofilm formation increases antibiotic tolerance and is a severe health threat (Husain and Ahmad 2013; Baptista et al. 2018; Jamil and Imran 2018).
Many strategies have been introduced to counter the menace of MDR bacteria in recent times and one such approach is the use of nanotechnology-developed novel nanomaterials that have different shapes and sizes and possess broad-spectrum antimicrobial action (Baptista et al. 2018). Nanoparticles (NPs) are promising candidates as they can not only demonstrate bactericidal action but can also act as carriers for conventional antibiotics and antibacterial compounds of natural origin (Wang et al. 2017). A wide range of materials have been investigated from liposomal to polymer-based nano-drug carriers. Metallic vectors, like gold NPs, are attractive core materials as they are essentially inert and non-toxic (Burygin et al. 2009). The most attractive aspect of nanoparticle-based drug delivery is the targeted delivery of various therapeutics to the site of infection effectively and safely. Drugs are delivered to the site of infection either bound to the large surface area of the NPs or encapsulated within the NP (Gholipourmalekabadi et al. 2017). This review not only summarizes the antibacterial potential of different types of nanoparticles but also discusses various nanostructural factors that contribute to the development of potent nano-antibiotics.
2 Why Nanomaterials as Antibacterial Agents?
Materials that are typically 0.2–100 nm in size, having high surface-to-volume ratio, are termed ‘nano’. These nanomaterials differ in their chemical, electrical, mechanical, optical, magnetic and electropotential properties from their bulk materials (Hajipour et al. 2012; Rudramurthy et al. 2016). Among all nanomaterials, most researches have focused on the synthesis and application of NPs. NPs are easy to synthesize, can enhance the solubility and stability of drugs and are biocompatible with target agents, and their modulated release makes them favourable candidates for use as drug vectors. The size of nanoparticles, along with their high surface-to-volume ratios, is responsible for achieving distinct functionality in drug delivery. This gives NPs an advantage over conventional therapies in the treatment of infections caused by drug-resistant bacteria (Rudramurthy et al. 2016; Gholipourmalekabadi et al. 2017). Silver nanoparticles (AgNPs) are the most studied nanomaterials and have been found to be the most effective NPs against pathogenic bacteria. However, other metal and metal oxide NPs synthesized from copper, zinc, titanium, tin, and iron have also demonstrated antibacterial potential (Dakal et al. 2016; Khan et al. 2016; Hemeg 2017; Al-Shabib et al. 2018a, b).
Conventional antibiotics suffer from poor membrane transport and thus have reduced potency (Andrade et al. 2013a, b), while NPs penetrate the membrane of host cells either by endocytosis or through interactions with surface lipids (Huang et al. 2010; Wang et al. 2017). The ability of NPs to confer physical protection against mechanisms of resistance enhances their therapeutic feasibility. Furthermore, since multiple drug combinations can be loaded into NPs, bacteria are less likely to develop resistance due to the complex mechanisms of action of different antimicrobials (Huh and Kwon 2011). However, a report on bacterial resistance against AgNPs has emerged recently (Panáček et al. 2018).
NPs demonstrate broad-spectrum bactericidal activity both against Gram-positive and Gram-negative bacteria and thus, have been employed as carriers for the delivery of antimicrobials (Rai et al. 2016; Wang et al. 2017; Zaidi et al. 2017; Hadiya et al. 2018). NPs are used as carriers because they protect antimicrobial agents from certain enzymes that either destroy or render the drug inactive. Secondly, they have the ability to deliver drugs to the target site and have the capability to carry and deliver multiple drug combinations (Huh and Kwon 2011; Rai et al. 2016; Wang et al. 2017; Zaidi et al. 2017; Hadiya et al. 2018). Moreover, NP vectors thwart pathogenic bacteria by prolonging the retention of drugs at the target site or by conjugation with the active molecules that bind a certain target (Wang et al. 2017). Conjugation of antibacterial drugs with NPs can help to overcome the therapeutic limitations of these drugs. Saha et al. (2007) demonstrated conjugation of the antibiotics ampicillin, streptomycin and kanamycin to gold NPs, which resulted in lowered minimum inhibitory concentrations (MIC) as compared to their free drugs counterparts against both Gram-positive and Gram-negative pathogens.
3 Antibacterial Action of NPs: Mechanistic Overview
The antibacterial activity of NPs against drug-resistant pathogenic bacteria depends on a number of factors discussed above. These antibacterial effects are attributed to various mechanisms of action such as interaction with the cell wall of bacteria, inhibition of biofilm, triggering host immune response, generation of reactive oxygen species (ROS) and interaction with DNA and proteins (Fig. 1) (Hemeg 2017; Singh et al. 2017; Wang et al. 2017; Zaidi et al. 2017; Siddiqi et al. 2018).
ROS generation that induces oxidative stress is one of the key mechanisms of action of NPs against bacteria (Rudramurthy et al. 2016). Bacteria form ROS via aerobic respiration, and its production is balanced by the antioxidant systems of bacteria, but increases in ROS generation can lead to oxidation of biomolecules and cell components, leading to cell damage (Yang et al. 2012). NPs generate distinctive ROS such as superoxide (O2−), hydrogen peroxide (H2O2), which can be neutralized by endogenous antioxidants, but singlet oxygen (1[O2]) and hydroxyl radicals (.OH) cause acute death of bacteria (Wang et al. 2017). Metallic NPs demonstrate antibacterial activity as they possess high surface-to-volume ratios, and this increased ratio is usually associated with increased ROS generation, including free radicals. Several investigations on NPs have highlighted the role of ROS-mediated oxidative stress in causing the death of drug-resistant bacteria as shown in Table 1. In one study, titanium oxide NPs (TIONPs) were shown to elicit ROS generation, causing damage to cellular components and subsequent cell death (Foster et al. 2011). In another investigation on the antibacterial action of NPs, AgNPs inhibited bacterial growth by generating superoxide and hydroxyl radicals, while the bactericidal effect of gold, nickel and silicon was attributed to the production of singlet oxygen (Zhang et al. 2013a, b). NPs made of zinc, graphene and copper have also been shown to trigger oxidative stress, leading to antibacterial effects against drug-resistant pathogens (Reddy et al. 2014a, b; Pan et al. 2016a, b; Ulloa-Ogaz et al. 2017).
Metal oxides demonstrate antibiotic action by releasing metal ions that enter the bacterial cell where they interact with the functional groups of proteins and nucleic acids. This interaction alters the structure of the cell, hinders enzymatic activity and interferes with the physiology of the bacterial cell (Wang et al. 2017). Gold functionalized superparamagnetic iron oxide nanoparticles interact with the disulphide bonds of bacterial proteins, which disrupts their metabolism and redox systems (Niemirowicz et al. 2014). In another study, Copper oxide NPs were shown to cause alteration of the expression of key proteins leading to inhibition of denitrification (Su et al. 2015a, b). Synergy between several antibacterial mechanisms was described as the possible reason for the bactericidal effect demonstrated by the graphene oxide/Cu/Ag nano-derivatives against drug resistant Gram-negative and Gram-positive pathogens (Jankauskaitė et al. 2016).
The cell wall and membrane protect bacteria from harsh environmental conditions and foreign agents. Thus non-oxidative NP antibacterial mechanisms affect the bacterial cell wall. Structural differences in the cell wall of Gram-negative and Gram-positive bacteria make the latter more vulnerable to the action of NPs (Wang et al. 2017). In a study conducted by Ansari et al., accumulation of NPs in the cell wall resulted in the formation of pits, holes and altered metabolism, leading to cell death (Ansari et al. 2014). TiONPs were shown to inhibit growth of E. coli by causing membrane leakage due to increased cell volume (Joost et al. 2015). In another study carried out to investigate the efficacy of gold nanoparticles (AuNPs) against Corynebacterium pseudotuberculosis, Transmission electron microscopy images showed that the thick cell wall of C. pseudotuberculosis was penetrated by AuNPs and accumulated as agglomerates inside the cell (Mohamed et al. 2017).
4 Nano-inhibitors of Quorum Sensing and Biofilm Formation
Biofilms are aggregations of bacteria adhered on a surface, or to each other, and encapsulated in a self-made matrix of extra polymeric substances (EPS). The EPS protects the cells from the entry of antibiotics and helps to confer tolerance to bacteria (Costerton et al. 1999; Bjarnsholt 2013). NPs disrupt biofilm formation by disturbing the EPS and by interfering with bacterial quorum sensing (QS). QS is a density-dependent communication system in some bacteria that coordinates the expression of various genes including those needed for biofilm production (Rutherford et al. 2014). Since QS systems promote the formation of drug-tolerant biofilms, it is not surprising that the interference of bacterial QS and, consequently, biofilm inhibition forms the basis for the development of new age antipathogenic drugs (LaSarre and Federle 2013; Jakobsen et al. 2017; Reen et al. 2018).
Numerous reports have emerged that have demonstrated the biofilm and QS inhibitory properties of NPs of which some are listed in Table 1. Silver nanowires (SNWs) demonstrated inhibition of QS-mediated biofilm production in Pseudomonas aeruginosa and violacein production in Chromobacterium violaceum ATCC 12472 (Wagh et al. 2013). AgCl-TiO2 nanoparticles inhibited QS-regulated production of violacein and synthesis of the QS signalling compounds, acylated homoserine lactones (AHL), in C. violaceum (Naik and Kowshik 2014). Lee et al. reported that ZnO nanoparticles considerably inhibited the QS-regulated production of virulence factors and biofilm formation in P. aeruginosa without affecting viability (Lee et al. 2014).
Vinoj et al. described the synthesis of an AHL lactonase-coated Gold nanoparticles. These nanoparticles reduced exopolysaccharide (EPS) production and consequently disturbed the biofilm architecture of the pathogen Proteus. This reduction in EPS and inhibition of biofilm was attributed to the increased degradation of QS signals (Vinoj et al. 2015). Green synthesized zinc nanostructures from an extract of Nigella sativa seed and demonstrated broad-spectrum QS inhibition against human and food pathogens (Al-Shabib et al. 2016). In another study, ZnONPs synthesized from the leaves of Ochradenus baccutus reduced biofilm formation in food-associated bacteria. These NPs were found to possess no serious toxic effects even at high doses. Moreover, they were found to have excellent antioxidant properties (Al-Shabib et al. 2018c). Monophasic tin dioxide nanoflowers (TONFs) assembled by rod-like nanostructures demonstrated inhibition of QS-regulated virulence in pathogens such as C. violaceum, P. aeruginosa and Serratia marcescens. Significant reduction in biofilm formation in all test pathogens was also observed, which was further validated by Confocal laser scanning microscopy images illustrating disturbed biofilm architecture (Al-Shabib et al. 2018a). Recently, phytofabricated AgNPs were shown to exhibit inhibition of QS-controlled functions and biofilm formation in drug-resistant pathogenic bacteria (Hussain et al. 2019).
ROS-mediated inhibition of biofilm has also been reported for NPs. AgNPs synthesized from the leaves of Mangifera indica demonstrated altered biofilm architecture in E. coli and S. mutans. Interaction of AgNPs with bacterial cell walls resulted in membrane damage, ROS production and biofilm inhibition (Qayyum et al. 2017). In another study, superparamagnetic iron oxide (Fe3O4) nanoparticles were tested against S. marcescens, E. coli, P. aeruginosa and Listeria monocytogenes. Iron oxide (Fe3O4) nanoparticles at sub-MIC levels demonstrated broad-spectrum inhibition of biofilm in all tested bacteria. These NPs also inhibited pre-formed mature biofilms. The proposed mechanism for these effects was the interaction of NPs with bacterial cells, which generated ROS and contributed to reduced biofilm formation (Al-Shabib et al. 2018b).
5 Factors Contributing to Antibacterial Activity of Nanomaterials
Many factors govern the antibacterial efficacy of nanomaterials. These aspects need to be kept in mind when designing and synthesizing nano-antibacterials to combat drug-resistant pathogens. Some of the key factors are discussed below:
5.1 Composition and Type of Nanomaterials
Different nanomaterials display different properties against diverse classes of bacteria. Considering the case of gold nanoparticles, they demonstrate poor antibacterial properties on their own but can potentiate the efficacy of some antibiotics when they are combined. Shaikh et al. reported the synthesis of cefotaxime-conjugated gold nanoparticles that demonstrated antibacterial activity against CTX-M producing drug-resistant strains of E. coli and K. pneumoniae (Shaikh et al. 2017). Similarly, liposomes conjugated with antibiotics have high efficiency against bacteria (Drulis-Kawa and Dorotkiewicz-Jach 2010). Thus, composition of nanoantimicrobials is an important consideration because the fundamental make-up of the material defines its surface chemistry and only the surface corona interacts with bacteria. Therefore, it is imperative to consider the composition of the nanomaterials for a specific target organism (Xie et al. 2014).
5.2 Surface Functionalization
Surface modification is performed to facilitate the passage of nanomaterials across biological barriers, but this should be done with caution as it might alter the properties of the original material. Positively charged NPs interact well with negatively charged prokaryotic surfaces, albeit with some toxicity (Thorley and Tetley 2013; Jamil and Imran 2018). Hydrophobic NPs are converted to hydrophilic ones by conjugation with polymers like polyethylene glycol (PEG) and chitosan on the surface of NPs. This process not only makes the NPs hydrophilic but also masks the host immune response and increases blood circulation time of PEGylated NPs. Hydrophobic NPs are captured by the host immune system and are not able to act against infection causing bacteria. Thus, this surface modification helps in the bioavailability of NPs (Kumari et al. 2010). Delivery of drugs encapsulated in nano-carriers to a specific site is termed targeted drug delivery. With targeted drug delivery, the site of infection receives the maximum concentration of the drug, and other organs are protected from side effects. Thus, the action of the drug will be maximized, localized and prolonged (Mahon et al. 2012; Mandal et al. 2013).
5.3 Size of Nanomaterials
Particle size is an important factor in nanotechnology, as the stability of the material depends on its size (Huh and Kwon 2011). Nanosized particles behave differently as compared to their bulk material and display size-dependent effects. As increased surface area contributes to increased activity, nanosize means more surface area is exposed and therapeutic efficacy is enhanced (Yang and Mai 2014). Guo et al. demonstrated that the activity of AgNPs increased with greater surface area, because increased surface area causes the release of more Ag+ leading to enhanced antibacterial activity (Guo et al. 2013).
6 From Bench to Bed Side: Clinical Application of Nano-antibacterials
Currently, few NP-based strategies are undergoing clinical trials to treat bacterial infections, probably because the high cost associated with the application of nanomaterials has limited their use as compared to conventional antibacterials. However, in case of specific clinical conditions, or high-risk patients nanobiotics may be particularly useful (Caster et al. 2017). For example, AgTive (NCT00337714) is a silver-based catheter with improved bactericidal properties. These catheters are manufactured from polyurethanes impregnated with AgNPs. AgTive releases considerably high amounts of Ag upon interaction with body fluids and intravenous solutions to reduce blood-stream infections (Antonelli et al. 2012). Another formulation comprised of AgNPs, chitosan and fluoride was developed and demonstrated antimicrobial properties. During clinical trials, nano silver fluoride was found to be very effective as an antibacterial against S. mutans and Lactobacilli and is used to prevent dental caries in children (Dos Santos et al. 2014).
Bio-kil® (Cargico, Taiwan) is a patented nanocomposite comprised of an inorganic metal part and organic quaternary ammonium part. This is a high affinity structure and possesses a strong electric field. Bio-kil® acts by damaging the membrane proteins of bacteria through its strong electric charge. Recently, it has demonstrated efficacy against MDR and environmental bacteria in ICUs (Lee et al. 2017). Another nanoformulation called Acticoat has been used for topically against bacteria. It is nanocrystalline silver that acts by releasing Ag into wounds and is reported to inhibit biofilm formation by P. aeruginosa and Acinetobacter baumannii in vitro (Potgieter and Meidany 2018). Similarly, the efficacy of SilvaSorb (NCT00659204) is being studied at Madigan Army Medical Center and is currently in Phase III clinical trials. SilvaSorb (AcryMed, Inc., Portland) is a gel made from AgNPs and is being investigated to compare the antimicrobial efficacy of a one-time application against standard antibacterial hand gel, in reducing bacterial counts from the hands of 40 patients seeded with S. marcescens.
7 Challenges of Ongoing and Future Research
Research carried out across the globe has shown the great potential that nanomaterials possess for the prevention and treatment of drug-resistant infection, but transferring the technology from the lab to the clinics remains a huge challenge. Assessment of interactions between nanoantimicrobials and cells, tissue and organs, dose calibrations and administration route are some of the big hurdles that are being encountered (Sandhiya et al. 2009). Biocompatibility is another issue as most results are based on in vitro studies. In vivo studies are required to investigate the toxicity, degradability and metabolism of NPs (Beyth et al. 2015). Studies have demonstrated the accumulation of NPs injected intravenously into organs like the colon, lungs, spleen, liver and lymphatics. Inhalation of NPs can lead to cytotoxicity at various respiratory organs by systemic circulation (Hagens et al. 2007; Poma and Giorgio 2008). NPs have demonstrated hepatotoxicity and nephrotoxicity due to the free radical-mediated oxidative stress generated via interaction of NPs with bacterial cell (Jong 2008).
Although NPs hold great potential as antibiotics for the future, there are still several questions related to their acute and long-term exposure to humans that need to be addressed. Several routes of exposure (oral and gastrointestinal tract, skin, organs of the respiratory system, blood stream) need very careful consideration when examining NP exposure (Matteis 2017). Physico-chemical properties of NPs affect their interaction with biological systems and their overall biological activity. This is well documented as various researchers have explored the anti-infection potential of metal and metal oxide NPs both in vitro and in vivo, but questions remain regarding the safety of these NPs. Compounding the problem is the vast number of different shapes, sizes, surface modifications that NPs possess; therefore, different methods are needed to evaluate their safety. Further, most studies report acute exposure rather than long-term exposure (Matteis 2017; Baptista et al. 2018; Warheit 2018). On the contrary, as research has also provided leads as to the specific mechanisms by which NPs exert toxic effects, careful surface modifications can be done to make them safe, stable and less toxic (Matteis 2017). The European Commission sponsored programmes FP7 and H2020 have helped to address concerns related to the safety of the nanoparticles (Warheit 2018). Furthermore, replacement, reduction and refinement policies related to in vivo studies have prompted regulatory agencies to realize the need for standard in vitro methodologies to establish toxicology profiles of NPs and direct labs to construct authentic and reliable databases of NPs based on their toxicological profiles. These steps will surely help in generating information on finding the right dosage at which a NP is safe for use as a therapeutic agent.
8 Conclusion
The emergence of drug resistance among pathogenic bacteria has made clinicians and researchers seek new novel drugs. In the last 10 years’ nanotechnology-derived therapeutics have taken centre stage as alternatives to conventional antibiotics. Vast reports on the antibacterial activity of NPs have made it imperative to study and understand the mechanism of their action. Now there is a need for serious consideration of the critical factors related to nanostructures for successful and safe implementation as nanobiotics. Further, detailed study is required to ensure the safety of these NPs before their clinical usage. Finally, we need to understand and address the financial feasibility of transferring these nanomaterials from the lab to the clinics.
References
Acharya, D., Singha, K. M., Pandey, P., Mohanta, B., Rajkumari, J., & Singha, L. P. (2018). Shape dependent physical mutilation and lethal effects of silver nanoparticles on bacteria. Scientific Reports, 8(1), 201.
Al-Shabib, N. A., Husain, F. M., Ahmed, F., et al. (2016). Biogenic synthesis of zinc oxide nanostructures from Nigella sativa seed: Prospective role as food packaging material inhibiting broad-spectrum quorum sensing and biofilm. Scientific Reports, 6. https://doi.org/10.1038/srep36761.
Al-Shabib, N. A., Husain, F. M., Ahmad, N., et al. (2018a). Facile synthesis of Tin Oxide hollow nanoflowers interfering with quorum sensing-regulated functions and bacterial biofilms. Journal of Nanomaterials, 2018, 1–11. https://doi.org/10.1155/2018/6845026.
Al-Shabib, N. A., Husain, F. M., Ahmed, F., et al. (2018b). Low temperature synthesis of superparamagnetic iron oxide (Fe3O4) nanoparticles and their ROS mediated inhibition of biofilm formed by food-associated bacteria. Frontiers in Microbiology, 9, 2567. https://doi.org/10.3389/fmicb.2018.02567.
Al-Shabib, N. A., Husain, F. M., Hassan, I., et al. (2018c). Biofabrication of zinc oxide nanoparticle from ochradenus baccatus leaves: Broad-spectrum antibiofilm activity, protein binding studies, and in vivo toxicity and stress studies. Journal of Nanomaterials, 2018, 1. https://doi.org/10.1155/2018/8612158.
Andrade, F., Rafael, D., Videira, M., Ferreira, D., Sosnik, A., & Sarmento, B. (2013a). Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Advanced Drug Delivery Reviews, 65, 1816–1827. https://doi.org/10.1016/j.addr.2013.07.020.
Andrade, F., Rafael, D., Videira, M., et al. (2013b). Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Advanced Drug Delivery Reviews, 65, 1816–1827. https://doi.org/10.1016/j.addr.2013.07.020.
Ansari, M. A., Khan, H. M., Khan, A. A., Pal, R., & Cameotra, S. S. (2013). Antibacterial potential of Al2O3 nanoparticles against multidrug resistance strains of Staphylococcus aureus isolated from skin exudates. Journal of Nanoparticle Research.
Ansari, M. A., Khan, H. M., Khan, A. A., et al. (2014). Interaction of Al 2 O 3 nanoparticles with Escherichia coli and their cell envelope biomolecules. Journal of Applied Microbiology, 116, 772–783. https://doi.org/10.1111/jam.12423.
Antonelli, M., De Pascale, G., Ranieri, V. M., et al. (2012). Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients. The Journal of Hospital Infection, 82, 101–107. https://doi.org/10.1016/j.jhin.2012.07.010.
Argueta-Figueroa, L., Morales-Luckie, R. A., Scougall-Vilchis, R. J., & Olea-Mejía, O. F. (2014). Synthesis, characterization and antibacterial activity of copper, nickel and bimetallic cu-Ni nanoparticles for potential use in dental materials. Prog Nat Sci Mater Int, 24, 321–328.
Ashfaq, M., Verma, N., & Khan, S. (2016). Copper/zinc bimetal nanoparticles-dispersed carbon nanofibers: A novel potential antibiotic material. Materials Science and Engineering: C, 59, 938–947.
Baptista, P. V., McCusker, M. P., Carvalho, A., et al. (2018). Nano-strategies to fight multidrug resistant bacteria-“A Battle of the Titans”. Frontiers in Microbiology, 9, 1–26. https://doi.org/10.3389/fmicb.2018.01441.
Beyth, N., Houri-haddad, Y., Domb, A., et al. (2015). Alternative antimicrobial approach: Nano-antimicrobial materials. Evidence-based Complementary and Alternative Medicine, 2015, 2015. https://doi.org/10.1155/2015/246012.
Bjarnsholt, T. (2013). The role of bacterial biofilms in chronic infections. APMIS, 121, 1–58. https://doi.org/10.1111/apm.12099.
Brown, A., Smith, K., Samuels, T. A., Lu, J., Obare, S., & Scott, M. E. (2012). Nanoparticles functionalized with Ampicillin destroy multiple antibiotic resistant isolates of Pseudomonas aeruginosa, enterobacter aerogenes and Methicillin resistant Staphylococcus aureus. Applied and Environmental Microbiology. https://doi.org/10.1128/AEM.06513-11.
Burygin, G. L., Khlebtsov, B. N., Shantrokha, A. N., et al. (2009). On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Research Letters, 4, 794–801. https://doi.org/10.1007/s11671-009-9316-8.
Caster, J. M., Patel, A. N., Zhang, T., & Wang, A. (2017). Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 9, 1. https://doi.org/10.1002/wnan.1416.
Cavassin, E. D., de Figueiredo, L. F., Otoch, J. P., Seckler, M. M., de Oliveira, R. A., Franco, F. F., Marangoni, V. S., Zucolotto, V., Levin, A. S., & Costa, S. F. (2015). Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria. Journal of Nanobiotechnology, 13(1), 64.
Cha, S. H., Hong, J., McGuffie, M., Yeom, B., VanEpps, J. S., & Kotov, N. A. (2015). Shape-dependent biomimetic inhibition of enzyme by nanoparticles and their antibacterial activity. ACS Nano, 9(9), 9097–9105.
Chakraborti, S., Mandal, A. K., Sarwar, S., Singh, P., Chakraborty, R., & Chakrabarti, P. (2014). Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island. Colloids and Surfaces. B, Biointerfaces, 121, 44–53.
Chang, T. Y., Chen, C. C., Cheng, K. M., Chin, C. Y., Chen, Y. H., Chen, X. A., Sun, J. R., Young, J. J., & Chiueh, T. S. (2017). Trimethyl chitosan-capped silver nanoparticles with positive surface charge: Their catalytic activity and antibacterial spectrum including multidrug-resistant strains of Acinetobacter baumannii. Colloids and Surfaces. B, Biointerfaces, 155, 61–70.
Chaurasia, A. K., Thorat, N. D., Tandon, A., Kim, J. H., Park, S. H., & Kim, K. K. (2016). Coupling of radiofrequency with magnetic nanoparticles treatment as an alternative physical antibacterial strategy against multiple drug resistant bacteria. Scientific Reports, 6, 1–13.
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999). Bacterial biofilms: A common cause of persistent infections. Science, 284(80), 1318. https://doi.org/10.1126/science.284.5418.1318.
Courvalin, P. (2016). Why is antibiotic resistance a deadly emerging disease? Clinical Microbiology and Infection, 22, 405–407. https://doi.org/10.1016/j.cmi.2016.01.012.
Cui, Y., Zhao, Y., Tian, Y., Zhang, W., Lü, X., & Jiang, X. (2012). The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials, 33(7), 2327–2333.
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V. (2016). Mechanistic basis of antimicrobial actions of silver nanoparticles. Frontiers in Microbiology, 7, 1–17. https://doi.org/10.3389/fmicb.2016.01831.
De Jong, W. H. (2008). 10.0000@www.iumj.indiana.edu@generic-B29BB9CC780E.pdf. 3:133–149. https:// https://doi.org/10.2147/IJN.S596
De Matteis, V. (2017). Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/in vivo toxicity evaluation. Toxics, 5. https://doi.org/10.3390/toxics5040029.
Ding, F., Songkiatisak, P., Cherukuri, P. K., Huang, T., & Xu, X. H. (2018). Size-Dependent Inhibitory Effects of Antibiotic Drug Nanocarriers against Pseudomonas aeruginosa. ACS omega, 3(1), 1231–1243.
Djafari, J., Marinho, C., Santos, T., Igrejas, G., Torres, C., Capelo, J. L., Poeta, P., Lodeiro, C., & Fernández-Lodeiro, J. (2016). New synthesis of gold-and silver-based nano-tetracycline composites. ChemistryOpen, 5(3), 206–212.
Doi, Y., Adams-Haduch, J. M., Peleg, A. Y., & D’Agata, E. M. C. (2012). The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting. Diagnostic Microbiology and Infectious Disease, 74, 34–38. https://doi.org/10.1016/j.diagmicrobio.2012.05.020.
Dos Santos, V. E., Filho, A. V., Ribeiro Targino, A. G., et al. (2014). A new “silver-Bullet” to treat caries in children – Nano silver fluoride: A randomised clinical trial. Journal of Dentistry, 42, 945–951. https://doi.org/10.1016/j.jdent.2014.05.017.
Drulis-Kawa, Z., & Dorotkiewicz-Jach, A. (2010). Liposomes as delivery systems for antibiotics. International Journal of Pharmaceutics, 387, 187–198. https://doi.org/10.1016/j.ijpharm.2009.11.033.
Ehsan, S., & Sajjad, M. (2017). Bioinspired synthesis of zinc oxide nanoparticle and its combined efficacy with different antibiotics against multidrug resistant bacteria. Journal of Biomaterials and Nanobiotechnology., 8(02), 159.
El-Zowalaty, M. E., Al-Ali, S. H. H., Husseiny, M. I., Geilich, B. M., Webster, T. J., & Hussein, M. Z. (2015). The ability of streptomycin-loaded chitosancoated magnetic nanocomposites to possess antimicrobial and antituberculosis activities. International Journal of Nanomedicine, 10, 3269–3274.
Esmaeillou, M., Zarrini, G., & Rezaee, M. A. (2017). Vancomycin capped with silver Nanoparticles as an antibacterial agent against multi-drug resistance bacteria. Advanced pharmaceutical bulletin., 7(3), 479.
Fernandes, P., & ScienceDirect. (2015). The global challenge of new classes of antibacterial agents: An industry perspective. Current Opinion in Pharmacology, 24, 7–11. https://doi.org/10.1016/j.coph.2015.06.003.
Foster, H. A., Ditta, I. B., Varghese, S., & Steele, A. (2011). Photocatalytic disinfection using titanium dioxide: Spectrum and mechanism of antimicrobial activity. Applied Microbiology and Biotechnology, 90, 1847–1868. https://doi.org/10.1007/s00253-011-3213-7.
Galanzha, E. I., Shashkov, E., Sarimollaoglu, M., Beenken, K. E., Basnakian, A. G., Shirtliff, M. E., Kim, J. W., Smeltzer, M. S., & Zharov, V. P. (2012). In vivo magnetic enrichment, photoacoustic diagnosis, and photothermal purging of infected blood using multifunctional gold and magnetic nanoparticles. PLoS One, 7(9), e45557.
Gholipourmalekabadi, M., Mobaraki, M., Ghaffari, M., & Zarebkohan, A. (2017). Send orders for print-reprints and e-prints to reprints@benthamscience.ae Targeted Drug Delivery Based on Gold Nanoparticle Derivatives Targeted Drug Delivery Based on Gold Nanoparticle Derivatives. https://doi.org/10.2174/138161282366617041910541.
Guo, L., Yuan, W., Lu, Z., & Li, C. M. (2013). Polymer/nanosilver composite coatings for antibacterial applications. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 439, 69–83. https://doi.org/10.1016/j.colsurfa.2012.12.029.
Hadiya, S., Liu, X., & Abd El-Hammed, W., et al. (2018). Levofloxacin-loaded nanoparticles decrease emergence of fluoroquinolone resistance in Escherichia coli. Microb Drug Resist 00:mdr.2017.0304. https://doi.org/10.1089/mdr.2017.0304.
Hagens, W. I., Oomen, A. G., de Jong, W. H., et al. (2007). What do we (need to) know about the kinetic properties of nanoparticles in the body? Regulatory Toxicology and Pharmacology, 49, 217–229. https://doi.org/10.1016/j.yrtph.2007.07.006.
Hajipour, M. J., Fromm, K. M., Akbar Ashkarran, A., et al. (2012). Antibacterial properties of nanoparticles. Trends in Biotechnology, 30, 499–511. https://doi.org/10.1016/j.tibtech.2012.06.004.
Hemeg, H. A. (2017). Nanomaterials for alternative antibacterial therapy. International Journal of Nanomedicine, 12, 8211–8225. https://doi.org/10.2147/IJN.S132163.
Huang, Y., Yu, F., Park, Y. S., et al. (2010). Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery. Biomaterials, 31, 9086–9091. https://doi.org/10.1016/j.biomaterials.2010.08.046.
Huang, N., Chen, X., Zhu, X., Xu, M., & Liu, J. (2017). Ruthenium complexes/polypeptide self-assembled nanoparticles for identification of bacterial infection and targeted antibacterial research. Biomaterials, 141, 296–313.
Huh, A. J., & Kwon, Y. J. (2011). “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Journal of Controlled Release, 156, 128–145. https://doi.org/10.1016/j.jconrel.2011.07.002.
Husain, F. M., & Ahmad, I. (2013). Doxycycline interferes with quorum sensing-mediated virulence factors and biofilm formation in Gram-negative bacteria. World Journal of Microbiology and Biotechnology, 29, 29. https://doi.org/10.1007/s11274-013-1252-1.
Hussain, A., Alajmi, M., Khan, M. A., Pervez, A., Ahmed, F., Amir, Samira, Husain, F. M., Khan, M. S., Gouse, S. K., Hassan, I., Khan, R. A., & Rehman, M. T. (2019). Biosynthesized silver nanoparticle (AgNP) from pandanus odorifer leaf extract exhibits anti-metastasis and Anti-Biofilm potentialso title. Frontiers in Microbiology, 10. https://doi.org/10.3389/fmicb.2019.00008.
Hwang, T. J., Carpenter, D., & Kesselheim, A. S. (2015). Paying for innovation: Reimbursement incentives for antibiotics. Science Translational Medicine, 7, 7–10.
Jakobsen, T. H., Tolker-Nielsen, T., & Givskov, M. (2017). Bacterial biofilm control by perturbation of bacterial signaling processes. International Journal of Molecular Sciences, 18. https://doi.org/10.3390/ijms18091970.
Jamil, B., & Imran, M. (2018). Factors pivotal for designing of nanoantimicrobials: An exposition. Critical Reviews in Microbiology, 44, 79–94. https://doi.org/10.1080/1040841X.2017.1313813.
Jankauskaitė, V., Vitkauskienė, A., Lazauskas, A., et al. (2016). Bactericidal effect of graphene oxide/Cu/Ag nanoderivatives against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus. International Journal of Pharmaceutics, 511, 90–97. https://doi.org/10.1016/j.ijpharm.2016.06.121.
Joost, U., Juganson, K., Visnapuu, M., et al. (2015). Photocatalytic antibacterial activity of nano-TiO2(anatase)-based thin films: Effects on Escherichia coli cells and fatty acids. Journal of Photochemistry and Photobiology B: Biology, 142, 178–185. https://doi.org/10.1016/j.jphotobiol.2014.12.010.
Khan, M. F., Ansari, A. H., Hameedullah, M., et al. (2016). Sol-gel synthesis of thorn-like ZnO nanoparticles endorsing mechanical stirring effect and their antimicrobial activities: Potential role as nano-antibiotics. Scientific Reports, 6. https://doi.org/10.1038/srep27689.
Khan, S., Khan, S. N., Meena, R., Dar, A. M., Pal, R., & Khan, A. U. (2017). Photoinactivation of multidrug resistant bacteria by monomeric methylene blue conjugated gold nanoparticles. Journal of Photochemistry and Photobiology, B: Biology, 174, 150–161.
Kim, D. Y., Kim, M., Shinde, S., Sung, J. S., & Ghodake, G. (2017). Cytotoxicity and antibacterial assessment of gallic acid capped gold nanoparticles. Colloids and Surfaces. B, Biointerfaces, 149, 162–167.
Kruk, T., Szczepanowicz, K., Stefańska, J., Socha, R. P., & Warszyński, P. (2015). Synthesis and antimicrobial activity of monodisperse copper nanoparticles. Colloids and Surfaces. B, Biointerfaces, 128, 17–22.
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces. B, Biointerfaces, 75, 1–18. https://doi.org/10.1016/j.colsurfb.2009.09.001.
Lai, H. Z., Chen, W. Y., Wu, C. Y., & Chen, Y. C. (2015). Potent antibacterial nanoparticles for pathogenic bacteria. ACS Applied Materials & Interfaces, 7(3), 2046–2054.
Lara, H. H., Ayala-Núñez, N. V., Turrent, L. D., & Padilla, C. R. (2010). Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World Journal of Microbiology and Biotechnology, 26(4), 615–621.
LaSarre, B., & Federle, M. J. (2013). Exploiting quorum sensing to confuse bacterial pathogens. Microbiology and Molecular Biology Reviews, 77, 73–111. https://doi.org/10.1128/MMBR.00046-12.
Lee, J. H., Kim, Y. G., Cho, M. H., & Lee, J. (2014). ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production. Microbiological Research, 169, 888–896. https://doi.org/10.1016/j.micres.2014.05.005.
Lee, W. S., Hsieh, T. C., Shiau, J. C., et al. (2017). Bio-Kil, a nano-based disinfectant, reduces environmental bacterial burden and multidrug-resistant organisms in intensive care units. Journal of Microbiology, Immunology, and Infection, 50, 737–746. https://doi.org/10.1016/j.jmii.2016.04.008.
Li, Y., Zhang, W., Niu, J., & Chen, Y. (2012). Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal oxide nanoparticles. ACS Nano, 6, 1–22.
Mahon, E., Salvati, A., Baldelli Bombelli, F., et al. (2012). Designing the nanoparticle-biomolecule interface for “targeting and therapeutic delivery”. Journal of Controlled Release, 161, 164–174. https://doi.org/10.1016/j.jconrel.2012.04.009.
Mandal, B., Bhattacharjee, H., Mittal, N., et al. (2013). Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine: Nanotechnology, Biology and Medicine, 9, 474–491. https://doi.org/10.1016/j.nano.2012.11.010.
Mohamed, M. M., Fouad, S. A., Elshoky, H. A., et al. (2017). Antibacterial effect of gold nanoparticles against Corynebacterium pseudotuberculosis. International Journal of Veterinary Science and Medicine, 5, 23–29. https://doi.org/10.1163/18763332-03901005.
Nagy, A., Harrison, A., Sabbani, S., Munson, R. S., Jr., Dutta, P. K., & Waldman, W. J. (2011). Silver nanoparticles embedded in zeolite membranes: Release of silver ions and mechanism of antibacterial action. International Journal of Nanomedicine, 6, 1833.
Naik, K., & Kowshik, M. (2014). Anti-quorum sensing activity of AgCl-TiO2 nanoparticles with potential use as active food packaging material. Journal of Applied Microbiology, 117, 972–983. https://doi.org/10.1111/jam.12589.
Niemirowicz, K., Swiecicka, I., Wilczewska, A. Z., Misztalewska, I., Kalska-Szostko, B., Bienias, K., et al. (2014). Gold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosa. International Journal of Nanomedicine, 9, 2217–2224. https://doi.org/10.2147/IJN.S56588.
Ocsoy, I., Yusufbeyoglu, S., Yılmaz, V., McLamore, E. S., Ildız, N., & Ülgen, A. (2017). DNA aptamer functionalized gold nanostructures for molecular recognition and photothermal inactivation of methicillin-resistant Staphylococcus aureus. Colloids and Surfaces. B, Biointerfaces, 159, 16–22.
Otari, S. V., Patil, R. M., Waghmare, S. R., Ghosh, S. J., & Pawar, S. H. (2013). A novel microbial synthesis of catalytically active Ag–alginate biohydrogel and its antimicrobial activity. Dalton Transactions, 42(27), 9966–9975.
Pan, W. Y., Huang, C. C., Lin, T. T., et al. (2016a). Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites. Nanomedicine: Nanotechnology, Biology and Medicine, 12, 431–438. https://doi.org/10.1016/j.nano.2015.11.014.
Pan, W. Y., Huang, C. C., Lin, T. T., Hu, H. Y., Lin, W. C., Li, M. J., & Sung, H. W. (2016b). Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites. Nanomedicine: Nanotechnology, Biology and Medicine, 12(2), 431–438.
Panáček, A., Kvítek, L., Smékalová, M., et al. (2018). Bacterial resistance to silver nanoparticles and how to overcome it. Nature Nanotechnology, 13, 65–71. https://doi.org/10.1038/s41565-017-0013-y.
Payne, J. N., Waghwani, H. K., Connor, M. G., Hamilton, W., Tockstein, S., Moolani, H., Chavda, F., Badwaik, V., Lawrenz, M. B., & Dakshinamurthy, R. (2016). Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity. Frontiers in Microbiology, 7, 607.
Perez, F., Endimiani, A., Hujer, K. M., & Bonomo, R. A. (2007). The continuing challenge of ESBLs. Current Opinion in Pharmacology, 7, 459–469. https://doi.org/10.1016/j.coph.2007.08.003.
Piddock, L. J. V. (2016). Assess drug-resistance phenotypes, not just genotypes. Nature Microbiology, 1, 16120. https://doi.org/10.1038/nmicrobiol.2016.120.
Poma, A., & Giorgio, M. L. Di. (2008). 基因毒性综述.Pdf. 571–585.
Potgieter, M. D., & Meidany, P. (2018). Evaluation of the penetration of nanocrystalline silver through various wound dressing mediums: An in vitro study. Burns, 44, 596–602. https://doi.org/10.1016/j.burns.2017.10.011.
Poulikakos, P., Tansarli, G. S., & Falagas, M. E. (2014). Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. European Journal of Clinical Microbiology & Infectious Diseases, 33, 1675–1685. https://doi.org/10.1007/s10096-014-2124-9.
Pradeepa, V. S. M., Mutalik, S., Udaya Bhat, K., Huilgol, P., & Avadhani, K. (2016). Preparation of gold nanoparticles by novel bacterial exopolysaccharide for antibiotic delivery. Life Sciences, 153, 171–179.
Qayyum, S., Oves, M., & Khan, A. U. (2017). Obliteration of bacterial growth and biofilm through ROS generation by facilely synthesized green silver nanoparticles. PLoS One, 12, 1–18. https://doi.org/10.1371/journal.pone.0181363.
Rai, M., Ingle, A. P., Gaikwad, S., et al. (2016). Nanotechnology based anti-infectives to fight microbial intrusions. Journal of Applied Microbiology, 120, 527–542. https://doi.org/10.1111/jam.13010.
Reddy, L. S., Nisha, M. M., Joice, M., & Shilpa, P. N. (2014a). Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae. Pharmaceutical Biology, 52, 1388–1397. https://doi.org/10.3109/13880209.2014.893001.
Reddy, L. S., Nisha, M. M., Joice, M., & Shilpa, P. N. (2014b). Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae. Pharmaceutical Biology, 52(11), 1388–1397.
Reen, F. J., Gutiérrez-Barranquero, J. A., Parages, M. L., & O Gara, F. (2018). Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition. Applied Microbiology and Biotechnology, 102, 2063–2073. https://doi.org/10.1007/s00253-018-8787-x.
Roy, A. S., Parveen, A., Koppalkar, A. R., & Prasad, M. A. (2010). Effect of nano-titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus aureus. Journal of Biomaterials and Nanobiotechnology., 1(01), 37.
Rudramurthy, G. R., Swamy, M. K., Sinniah, U. R., & Ghasemzadeh, A. (2016). Nanoparticles: alternatives against drug-resistant pathogenic microbes. Molecules, 21, 1–30. https://doi.org/10.3390/molecules21070836.
Rutherford, S. T., Bassler, B. L., Delany, I., et al. (2014). Bacterial quorum sensing : Its role in virulence and possibilities for its Control. Cold Spring Harbor Perspectives in Medicine, 1;2(11). https://doi.org/10.1101/cshperspect.a012427.
Saeb, A., Alshammari, A. S., Al-Brahim, H., & Al-Rubeaan, K. A. (2014). Production of silver nanoparticles with strong and stable antimicrobial activity against highly pathogenic and multidrug resistant bacteria. Scientific World Journal, 704708.
Saha, B., Bhattacharya, J., Mukherjee, A., Ghosh, A. K., Santra, C. R., & Dasgupta, A. K. K. P. (2007). In Vitro Structural and functional evaluation of gold nanoparticles conjugated antibiotics. Nanoscale Research Letters, 2, 614.
Sandhiya, S., Dkhar, S. A., & Surendiran, A. (2009). Emerging trends of nanomedicine – an overview. Fundamental & Clinical Pharmacology, 23, 263–269. https://doi.org/10.1111/j.1472-8206.2009.00692.x.
Shaikh, S., Rizvi, S. M. D., Shakil, S., et al. (2017). Synthesis and characterization of cefotaxime conjugated gold nanoparticles and their use to target drug-resistant CTX-M-Producing Bacterial Pathogens. Journal of Cellular Biochemistry, 118, 2802–2808. https://doi.org/10.1002/jcb.25929.
Shaker, M. A., & Shaaban, M. I. (2017). Formulation of carbapenems loaded gold nanoparticles to combat multi-antibiotic bacterial resistance: in vitro antibacterial study. International Journal of Pharmaceutics, 15;525(1), 71–84.
Siddiqi, K. S., Husen, A., & Rao, R. A. K. (2018). A review on biosynthesis of silver nanoparticles and their biocidal properties. Journal of nanobiotechnology, 16, 14. https://doi.org/10.1186/s12951-018-0334-5.
Singh, R., Smitha, M. S., & Singh, S. P. (2014). The role of nanotechnology in combating multi-drug resistant bacteria. Journal of Nanoscience and Nanotechnology, 14(7), 4745–4756.
Singh, B. N., Prateeksha, U. D. K., et al. (2017). Bactericidal, quorum quenching and anti-biofilm nanofactories: A new niche for nanotechnologists. Critical Reviews in Biotechnology, 37, 525–540. https://doi.org/10.1080/07388551.2016.1199010.
Su, Y., Zheng, X., Chen, Y., et al. (2015a). Alteration of intracellular protein expressions as a key mechanism of the deterioration of bacterial denitrification caused by copper oxide nanoparticles. Scientific Reports, 5, 1–11. https://doi.org/10.1038/srep15824.
Su, Y., Zheng, X., Chen, Y., Li, M., & Liu, K. (2015b). Alteration of intracellular protein expressions as a key mechanism of the deterioration of bacterial denitrification caused by copper oxide nanoparticles. Scientific Reports, 5, 15824.
Thapa, R., Bhagat, C., Shrestha, P., Awal, S., & Dudhagara, P. (2017). Enzyme-mediated formulation of stable elliptical silver nanoparticles tested against clinical pathogens and MDR bacteria and development of antimicrobial surgical thread. Annals of Clinical Microbiology and Antimicrobials, 16(1), 39.
Thorley, A. J., & Tetley, T. D. (2013). New perspectives in nanomedicine. Pharmacology & Therapeutics, 140, 176–185. https://doi.org/10.1016/j.pharmthera.2013.06.008.
Ulloa-Ogaz, A. L., Piñón-Castillo, H. A., Muñoz-Castellanos, L. N., et al. (2017). Oxidative damage to Pseudomonas aeruginosa ATCC 27833 and Staphylococcus aureus ATCC 24213 induced by CuO-NPs. Environmental Science and Pollution Research, 24, 22048–22060. https://doi.org/10.1007/s11356-017-9718-6.
Vinoj, G., Pati, R., Sonawane, A., & Vaseeharan, B. (2015). In vitro cytotoxic effects of gold nanoparticles coated with functional acyl homoserine lactone lactonase protein from Bacillus licheniformis and their antibiofilm activity against proteus species. Antimicrobial Agents and Chemotherapy, 59, 763–771. https://doi.org/10.1128/AAC.03047-14.
Wagh, M. S., Patil, R. H., Thombre, D. K., et al. (2013). Evaluation of anti-quorum sensing activity of silver nanowires. Applied Microbiology and Biotechnology, 97, 3593–3601. https://doi.org/10.1007/s00253-012-4603-1.
Wang, L., Hu, C., & Shao, L. (2017). The antimicrobial activity of nanoparticles: Present situation and prospects for the future. International Journal of Nanomedicine, 12, 1227–1249. https://doi.org/10.2147/IJN.S121956.
Warheit, D. B. (2018). Hazard and risk assessment strategies for nanoparticle exposures: How far have we come in the past 10 years? [ version 1; referees: 2 approved]. Referee Status, 7, 1–14. https://doi.org/10.12688/f1000research.12691.1.
Xie, S., Tao, Y., Pan, Y., et al. (2014). Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. Journal of Controlled Release, 187, 101–117. https://doi.org/10.1016/j.jconrel.2014.05.034.
Yang, C. C., & Mai, Y. W. (2014). Thermodynamics at the nanoscale: A new approach to the investigation of unique physicochemical properties of nanomaterials. Materials Science and Engineering R: Reports, 79, 1–40. https://doi.org/10.1016/j.mser.2014.02.001.
Yang, L., Wen, Z., Junfeng, N., & Yongsheng, C. (2012). Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano, 6, 5164–5173. https://doi.org/10.1021/nn300934k.
Zaidi, S., Misba, L., & Khan, A. U. (2017). Nano-therapeutics: A revolution in infection control in post antibiotic era. Nanomedicine: Nanotechnology, Biology and Medicine, 13, 2281–2301. https://doi.org/10.1016/j.nano.2017.06.015.
Zhang, W., Li, Y., Niu, J., & Chen, Y. (2013a). Photogeneration of reactive oxygen species on uncoated silver, gold, nickel, and silicon nanoparticles and their antibacterial effects. Langmuir, 29, 4647–4651. https://doi.org/10.1021/la400500t.
Zhang, W., Li, Y., Niu, J., & Chen, Y. (2013b). Photogeneration of reactive oxygen species on uncoated silver, gold, nickel, and silicon nanoparticles and their antibacterial effects. Langmuir, 29(15), 4647–4651.
Zhang, Y., Zhu, P., Li, G., Wang, W., Chen, L., Lu, D. D., et al. (2015). Highly stable and re-dispersible nano cu hydrosols with sensitively size-dependent catalytic and antibacterial activities. Nanoscale, 7, 13775–13783.
Zhao, Y., Ye, C., Liu, W., Chen, R., & Jiang, X. (2014). Tuning the composition of AuPt bimetallic nanoparticles for antibacterial application. Angew Chem Int, 53, 8127–8131. https://doi.org/10.1002/anie.201401035.
Zhou, Z., Peng, S., Sui, M., Chen, S., Huang, L., Xu, H., & Jiang, T. (2018). Multifunctional nanocomplex for surface-enhanced Raman scattering imaging and near-infrared photodynamic antimicrobial therapy of vancomycin-resistant bacteria. Colloids and Surfaces. B, Biointerfaces, 161, 394–402.
Acknowledgement
The authors are grateful to the King Saud University and Aligarh Muslim University for providing research facilities.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Husain, F.M. et al. (2019). Nanoparticles as New Emerging Antibacterials: Potentials and Limitations. In: Ahmad, I., Ahmad, S., Rumbaugh, K. (eds) Antibacterial Drug Discovery to Combat MDR. Springer, Singapore. https://doi.org/10.1007/978-981-13-9871-1_25
Download citation
DOI: https://doi.org/10.1007/978-981-13-9871-1_25
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9870-4
Online ISBN: 978-981-13-9871-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)